Method of treating glycogen storage disease type IX using acid alpha-glucosidase
Abstract:
The disclosure relates, in general, to Glycogen Storage Disease and, in particular, to a method of treating Glycogen Storage Disease Type IX and to compounds and compositions suitable for use in such a method, including acid alpha-glucosidase.
Public/Granted literature
Information query
Patent Agency Ranking
0/0